CD44 and cancer: These studies also revealed that increased RANK signaling elicits other cellular changes associated with transformation and cancer stemness, such as increased cell motility, expansion of the cancer stem cell population (i. e. CD44(+); CD24(-)), and anchorage-independent growth.